The PReMA CEO, upon the decision of the CCC, shall apply one or more of the following sanctions to the company found in breach of the Code:-
|
| 7.1
|
Refer the complaint to the International Federation of Pharmaceutical Manufacturers’ Association (IFPMA).
|
| 7.2
| Refer the complaint and the Sub-committee’s finding to the head office and regional office of the offending company.
|
| 7.3
| Suspend the offending company’s membership for not more than 3 years.
|
| 7.4
| Debar the offending company from membership of the Association, under Section 12.7 (2) of the PReMA Articles of Association.
|
| 7.5
| A written undertaking that the practice complained of, will be discontinued on or before a date to be determined by the CCC.
|
| 7.6
| Retraction statements, including corrective letters and advertising, to be issued by the Subject Company, subject to the approval of the CCC prior to release. It is the company’s responsibility to ensure that the requirements of the CCC are met and to immediately inform and provide evidence to PReMA of their fulfillment.
|
| 7.7
| The issuing of a fine by PReMA to the Subject Company as per follows:
|
|
| 7.7.1
| A fine not exceeding the value of 100,000 Baht, for a first offence.
|
| 7.7.2
| A fine not exceeding the value of 500,000 Baht for a second offence, within a 12 month period.
|
| 7.7.3
| The fine to be paid within 30 days of being advised, subject to any appeal that may be lodged under Section 6.8 of the Code.
|
|
|
|
